Featured

Highly Cited Researchers 2023: The evolution of our evaluation and selection policy to support a robust scholarly landscape

David Pendlebury

Head of Research Analysis at the Institute for Scientific Information

arrow_forward Read more
Academia and Government
Tenth Annual “Research Fronts Report” Highlights Hot and Emerging Fields
arrow_forward Read more
Clarivate Insights
How Clarivate uses Artificial Intelligence you can trust to transform your world
arrow_forward Read more
Life Sciences and Healthcare
January 25, 2018

New blood pressure guidelines arrive: key takeaways for clinicians and patients
Life Sciences and Healthcare
January 25, 2018

Health technology assessment agencies play pivotal role in patient access to medicines
Life Sciences and Healthcare
January 23, 2018

As biopharma innovation accelerates, partnering follows suit
Life Sciences and Healthcare
January 22, 2018

Steps taken to streamline regulatory processes in the Middle East
Life Sciences and Healthcare
January 17, 2018

Sublocade approval likely to be a game changer in the U.S. fight against opioid addiction
Life Sciences and Healthcare
January 12, 2018

Device Advice! The Value and Use of PRO Measures in Assessing Medical Devices
Life Sciences and Healthcare
January 9, 2018

Predictive analytics yield better disease forecasting: the example of MS
Life Sciences and Healthcare
January 4, 2018

Shifts in industry landscape: With uncertainty ahead, time to build enterprise resilience
Life Sciences and Healthcare
December 28, 2017

Impactability is the next step for predictive analytics
Life Sciences and Healthcare
December 14, 2017

Everything old is new again: bacteriophage therapy
Life Sciences and Healthcare
December 12, 2017

Migraine: a revolution in prevention
Life Sciences and Healthcare
December 8, 2017

How can pharma reps respect physicians’ time? We asked 20 doctors
Life Sciences and Healthcare
December 7, 2017

The latest plague outbreak in Sub-Saharan Africa
Life Sciences and Healthcare
December 5, 2017

The impact of the changing regulatory environment on the approval of new medicines, 2007-2016
Life Sciences and Healthcare
November 30, 2017

Green light to market Hemlibra for hemophilia A with inhibitors in the US
close-link